双重HER2抑制:两个比一个好吗?
Matthew R Strickland1, Samuel J Klempner1
1Department of Medicine, Division of Hematology-Oncology, Massachusetts General Cancer Center, Boston, MA, USA.
用HLX22和HLX02加上化疗对HER2进行双重向,在HER2+胃食道癌症中显示出令人鼓舞的结果. 在竞争激烈的HER2治疗领域,进一步发展是不确定的.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫治疗是一种免疫疗法.
背景情况:
- HER2阳性 (HER2+) 胃食道癌是一个重大的临床挑战.
- 目前对HER2+胃食道癌的治疗策略通常涉及HER2向治疗.
- 需要新的治疗方法来改善这种患者群体的治疗结果.
研究的目的:
- 评估双 HER2 向策略在前线 HER2+胃食道癌症中的有效性和安全性.
- 为了探索HLX22,HLX02 (trastuzumab生物类似药) 和capecitabine/oxaliplatin化疗的组合.
主要方法:
- 进行了一项随机前线II期临床试验.
- 纳入了患有HER2+胃食道癌的患者.
- 治疗臂包括HLX22,HLX02和化疗的组合.
主要成果:
- 组合疗法显示了令人鼓舞的客观反应率.
- 无进展生存数据也呈阳性.
- 安全性和耐受性概况需要进一步评估.
结论:
- 双 HER2 向与 HLX22 和 HLX02 结合化疗显示在 HER2+ 胃食道癌症的承诺.
- 这种组合策略的临床实用性和未来发展需要进一步研究.
- 针对HER2的治疗方法的竞争格局对新的组合提出了挑战.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
08:29Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
相关概念视频
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistent Cancers
